Grand Valley Oncology — Grand Junction, Colorado

Public research footprint of Grand Valley Oncology, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type · Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma

Recently updated registry entries

NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)
NCT03419234 — Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone… (Active Not Recruiting)
NCT05256225 — Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Grand Valley Oncology?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.